SBIR Phase II: Applying Language Understanding at the Point of Care to Enhance Clinical Documentation and Realize Quality Improvements
SBIR 第二阶段:在护理点应用语言理解来增强临床记录并实现质量改进
基本信息
- 批准号:1330136
- 负责人:
- 金额:$ 40.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-10-01 至 2015-09-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The innovation presented in this proposal is a new paradigm for capturing critical quality information at the point-of-care using advanced technologies in an intuitive workflow. Healthcare quality and cost represent top national priorities. An increasingly common strategy to improve outcomes and value of care is performance assessment to promote best practices. Over decades, the most successful quality improvement (QI) programs have been heavily data-reliant. These programs require identifying patients that fit specific quality measures and assuring their care meets national guidelines. Linking patients to quality measures is the rate limiting step, involving an overwhelming amount of manual labor to review narrative notes one at a time and link them to an appropriate subset of hundreds of known quality measures. Leveraging a robust platform proven in Phase I, the proposed Phase II solution offers an automated approach to capturing a set of quality measures in real-time. The output will provide rich and compliant documentation enhanced with quality measures that feed the electronic health record (EHR) and downstream clinical, operational, and financial hospital systems through standard protocols. The goal is a disruptive change that will fast-track national initiatives and enable a safer and more efficient healthcare system.The broader/commercial impact of this program is to further national healthcare goals of reducing cost and improving quality in care. The approach leverages increased breadth, depth, and accuracy of patient data captured at the point of care. The most aggressive national initiatives encourage capturing a small portion of the hundreds of known quality measures. Accelerating capture and use of quality measures is an opportunity to meaningfully improve a healthcare system that lags in quality and cost. Impact must also be considered at a personal level. There is a cost to care within a system where quality is not documented and tracked. A typical example out of the hundreds of defined measures is ventilator associated pneumonia (VAP). Multiple studies on manual programs to document VAP and leverage care algorithms demonstrate greater than 40% reduction in mortality and 20% reduction in cost. VAP, though common, did not make the top 15 list of measures required by the government in 2014 because it is too difficult to capture. There is currently no automated approach to capture this quality measure. Addressing technical limitations in documenting quality measures will expand QI reach and save lives.
该提案中提出的创新是在直观的工作流程中使用高级技术在护理点捕获关键质量信息的新范例。医疗质量和成本是国家的首要任务。改善护理成果和价值的一个日益普遍的战略是进行绩效评估,以促进最佳做法。几十年来,最成功的质量改进(QI)计划一直严重依赖数据。这些计划要求确定符合特定质量标准的患者,并确保他们的护理符合国家指南。将患者与质量指标联系起来是速度限制步骤,需要大量的体力劳动,一次审阅一个叙述性笔记,并将它们链接到数百个已知质量指标的适当子集。利用在第一阶段经过验证的强大平台,建议的第二阶段解决方案提供了一种自动方法来实时捕获一组质量衡量标准。输出将提供丰富和合规的文档,并通过标准协议提供电子健康记录(EHR)和下游临床、运营和财务医院系统的质量措施。目标是一项颠覆性的变化,将快速跟踪国家倡议,并实现更安全、更高效的医疗体系。该计划的更广泛/更商业影响是促进降低成本和提高医疗质量的国家医疗目标。该方法利用了在护理点捕获的患者数据的更大广度、深度和准确性。最激进的国家倡议鼓励捕获数百项已知质量指标中的一小部分。加快质量措施的获取和使用,是有意义地改善在质量和成本方面落后的医疗体系的机会。影响也必须在个人层面上考虑。在一个没有记录和跟踪质量的系统中,护理是有成本的。在数百项已定义的措施中,一个典型的例子是呼吸机相关性肺炎(VAP)。对记录VAP和利用护理算法的手动程序的多项研究表明,死亡率降低了40%以上,成本降低了20%。VAP虽然很常见,但没有进入2014年政府要求的15项措施之列,因为它太难捕捉了。目前还没有自动化的方法来获取这一质量衡量标准。解决记录质量措施的技术限制将扩大QI覆盖范围并拯救生命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raj Tiwari其他文献
Have we mis-PRONOUNCEd the cardiovascular risk of GnRH agonists? A critical appraisal of the PRONOUNCE trial
我们是否错误地发音了促性腺激素释放激素激动剂的心血管风险?对 PRONOUNCE 试验的批判性评价
- DOI:
10.1038/s41391-021-00483-5 - 发表时间:
2022-01-04 - 期刊:
- 影响因子:5.800
- 作者:
Raj Tiwari;Katherine Lajkosz;Neil Fleshner;Christopher J. D. Wallis - 通讯作者:
Christopher J. D. Wallis
Role of estrogen in thyroid tumor neo-vascularization
- DOI:
10.1016/j.otohns.2009.06.172 - 发表时间:
2009-09-01 - 期刊:
- 影响因子:
- 作者:
YuShan Wilson;Robert Suriano;Shilpi Rajoria;Raj Tiwari;Stimson Schantz - 通讯作者:
Stimson Schantz
PSMA PET/CT-DETECTED MESORECTAL NODAL METASTASIS IN BIOCHEMICALLY RECURRENT PROSTATE CANCER PATIENTS
- DOI:
10.1016/j.urolonc.2024.01.078 - 发表时间:
2024-03-01 - 期刊:
- 影响因子:
- 作者:
Rashid Sayyid;Rui Bernardino;Zizo Al-Daqqaq;Raj Tiwari;Jess Cockburn;Shagana Vijayakanthan;Mohamad Baker Berjaoui;Ur Metser;Alejandro Berlin;Neil E. Fleshner;Yazan Qaoud - 通讯作者:
Yazan Qaoud
ASSOCIATION OF PROTON PUMP INHIBITORS CUMULATIVE USE WITH PROSTATE CANCER RISK AND ADVERSE OUTCOMES: A POPULATION-BASED ANALYSIS
- DOI:
10.1016/j.urolonc.2024.01.249 - 发表时间:
2024-03-01 - 期刊:
- 影响因子:
- 作者:
Rashid Sayyid;Raj Tiwari;Zizo Al-Daqqaq;Katherine Lajkosz;Jess G. Cockburn;Rui Bernardino;Majed Al-Rumayyan;Neil E. Fleshner;Bo Zhang;Andrew Wilton;Refik Saskin - 通讯作者:
Refik Saskin
Seroprevalence of anti HCV antibodies among blood donors in Kathmandu valley ,
加德满都谷地献血者中抗 HCV 抗体的血清阳性率
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Correspondence Mr Bisnu;Raj Tiwari;S. Karki;Ghimire P;Tiwari Br - 通讯作者:
Tiwari Br
Raj Tiwari的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
镁碳耐火材料中Fe2AlB2-Al2O3复合粉体物相重构协同强韧化及材料抗渣侵蚀机理研究
- 批准号:JCZRQN202500380
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
VO2相变材料基准光学纳米腔结构的宽温域自适应热隐身薄膜设计
- 批准号:JCZRQN202500547
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
硫缺陷调控多晶相SnS2-PANI复合膜构筑及其光电催化机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
高盐深层油藏CO2混相驱固相析出微观机理研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
参附方靶向SOCS3/JAK2相互作用调控JAK2/STAT3通路改善肝缺血再灌注损伤的物质基础与作用机理研究
- 批准号:JCZRLH202500794
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于新型两相胺吸收法的船舶CO2高效低能耗捕集机制研究
- 批准号:BMHY25E060001
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
CO2驱替作用下陆相页岩凝析气微观相态演化与多尺度流动耦合机制
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
负载叶绿素和CaO2纳米水凝胶通过两时相调控ROS对牙周炎的作用机制研究
- 批准号:QN25H140006
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
PFKFB1通过调节PLIN3-VDAC2相互作用增强脂肪酸氧化促进结直肠癌肝转移的作用及机制探究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
中侏罗世温室气候期高 CO2 制约下湖相砂泥岩早期成岩作用及油气储集意义
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
- 批准号:
2321862 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Innovative Glass Inspection for Advanced Semiconductor Packaging
SBIR 第二阶段:先进半导体封装的创新玻璃检测
- 批准号:
2335175 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Intelligent Language Learning Environment
SBIR第二阶段:智能语言学习环境
- 批准号:
2335265 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: FlashPCB Service Commercialization and AI Component Package Identification
SBIR第二阶段:FlashPCB服务商业化和AI组件封装识别
- 批准号:
2335464 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
- 批准号:
2335504 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Sodium-Based Solid-State Batteries for Stationary Energy Storage
SBIR第二阶段:用于固定储能的钠基固态电池
- 批准号:
2331724 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women
SBIR II 期:无网、无吊带的微创治疗女性压力性尿失禁
- 批准号:
2233106 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
- 批准号:
2226026 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: High-Performance Batteries to Decarbonize Heavy Duty Construction Equipment
SBIR 第二阶段:高性能电池使重型建筑设备脱碳
- 批准号:
2335320 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Technology for Stimulating the Herd Instinct of Livestock to Reduce Environmental Impact
SBIR第二阶段:刺激牲畜的群体本能以减少环境影响的技术
- 批准号:
2335554 - 财政年份:2024
- 资助金额:
$ 40.57万 - 项目类别:
Cooperative Agreement